The use of specialty drugs in the U.S. has skyrocketed in recent years driven primarily by an increase in chronic condition diagnosis and the number of new medications on the market. Krishnanjan ...
Entrectinib for treating NTRK fusion-positive solid tumours in people 12 years and over (terminated appraisal) TA1118 7 January 2026 7 January 2026 ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果